Cargando…

GDF-15 predicts cardiovascular events in acute chest pain patients

BACKGROUND: Treatment of patients presenting with possible acute myocardial infarction (AMI) is based on timely diagnosis and proper risk stratification aided by biomarkers. We aimed at evaluating the predictive value of GDF-15 in patients presenting with symptoms suggestive of AMI. METHODS: Consecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tzikas, Stergios, Palapies, Lars, Bakogiannis, Constantinos, Zeller, Tanja, Sinning, Christoph, Baldus, Stephan, Bickel, Christoph, Vassilikos, Vassilios, Lackner, Karl J., Zeiher, Andreas, Münzel, Thomas, Blankenberg, Stefan, Keller, Till
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542604/ https://www.ncbi.nlm.nih.gov/pubmed/28771550 http://dx.doi.org/10.1371/journal.pone.0182314

Ejemplares similares

Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay
por: Liebetrau, Christoph, et al.
Publicado: (2015)

Troponin I Assay for Identification of a Significant Coronary Stenosis in Patients with Suspected Acute Myocardial Infarction and Wide QRS Complex
por: von Jeinsen, Beatrice, et al.
Publicado: (2016)

Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease
por: Kraus, Daniel, et al.
Publicado: (2018)

Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain
por: Boeckel, Jes-Niels, et al.
Publicado: (2018)

A Case of a Paracardial Osteophyte Causing Atrial Compression
por: Tzikas, Stergios, et al.
Publicado: (2016)

A Patient-Oriented App (ThessHF) to Improve Self-Care Quality in Heart Failure: From Evidence-Based Design to Pilot Study
por: Bakogiannis, Constantinos, et al.
Publicado: (2021)

Low Homoarginine Levels in the Prognosis of Patients With Acute Chest Pain
por: Atzler, Dorothee, et al.
Publicado: (2016)

Multiple Biomarkers and Atrial Fibrillation in the General Population
por: Schnabel, Renate B., et al.
Publicado: (2014)

Iron therapy and severe arrhythmias in HFrEF: rationale, study design, and baseline results of the RESAFE‐HF trial
por: Bakogiannis, Constantinos, et al.
Publicado: (2023)

Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease
por: Fluschnik, Nina, et al.
Publicado: (2018)

Risk Factors of Coronary Artery Disease in Secondary Prevention—Results from the AtheroGene—Study
por: Zengin, Elvin, et al.
Publicado: (2015)

An Asymptomatic Patient with an Additional Cardiac Chamber Giant Left Atrial Appendage
por: Evangeliou, Alexandros P., et al.
Publicado: (2020)

Clinical Validation of an Artificial Intelligence–Based Tool for Automatic Estimation of Left Ventricular Ejection Fraction and Strain in Echocardiography: Protocol for a Two-Phase Prospective Cohort Study
por: Hadjidimitriou, Stelios, et al.
Publicado: (2023)

Right atrium size in the general population
por: Keller, Karsten, et al.
Publicado: (2021)

Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery
por: Lazaridis, Charalampos, et al.
Publicado: (2020)

GDF15 and Cardiac Cells: Current Concepts and New Insights
por: Rochette, Luc, et al.
Publicado: (2021)

Cross-Sectional Associations between Homoarginine, Intermediate Phenotypes, and Atrial Fibrillation in the Community—The Gutenberg Health Study
por: Niekamp, Christoph, et al.
Publicado: (2018)

GDF15 and Growth Control
por: Emmerson, Paul J., et al.
Publicado: (2018)

Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review
por: Papadopoulos, Christodoulos, et al.
Publicado: (2020)

Depression in Atrial Fibrillation in the General Population
por: Schnabel, Renate B., et al.
Publicado: (2013)

The impact of atrial mechanical function on age‐dependent presentation of neurocardiogenic syncope
por: Sotiriadou, Melani, et al.
Publicado: (2021)

Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers
por: Kyriakou, Panagiota, et al.
Publicado: (2018)

Relations of Sex to Diagnosis and Outcomes in Acute Coronary Syndrome
por: Sörensen, Nils Arne, et al.
Publicado: (2018)

Novel DNA Methylation Sites Influence GPR15 Expression in Relation to Smoking
por: Haase, Tina, et al.
Publicado: (2018)

The Role of GDF15 as a Myomitokine
por: Johann, Kornelia, et al.
Publicado: (2021)

GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism
por: Rochette, Luc, et al.
Publicado: (2021)

Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation
por: Ali, Muhammad, et al.
Publicado: (2020)

Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy
por: Fejzo, M, et al.
Publicado: (2023)

Sex Differences in Correlates of Intermediate Phenotypes and Prevalent Cardiovascular Disease in the General Population
por: Schnabel, Renate B., et al.
Publicado: (2015)

Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression
por: Adolph, Timon E., et al.
Publicado: (2018)

GDF‐15 in solid vs non‐solid treatment‐naïve malignancies
por: Arfsten, Henrike, et al.
Publicado: (2019)

Exercise increases circulating GDF15 in humans
por: Kleinert, Maximilian, et al.
Publicado: (2018)

Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System
por: Zeller, Tanja, et al.
Publicado: (2017)

GDF15 : A modulator of immunity and a predictive biomarker of cardiovascular events : A strategy in COVID-19
por: Rochette, Luc, et al.
Publicado: (2023)

GDF15 promotes EMT and metastasis in colorectal cancer
por: Li, Chen, et al.
Publicado: (2015)

TGF-β contamination of purified recombinant GDF15
por: Olsen, Oddrun Elise, et al.
Publicado: (2017)

Control of glioma cell migration and invasiveness by GDF-15
por: Codó, Paula, et al.
Publicado: (2016)

GDF-15 como Biomarcador em Doenças Cardiovasculares
por: May, Bruna Miers, et al.
Publicado: (2021)

Design and Synthesis of AMPK Activators and GDF15 Inducers
por: Zhang, Meijian, et al.
Publicado: (2023)

GDF15 Suppresses Lymphoproliferation and Humoral Autoimmunity in a Murine Model of Systemic Lupus Erythematosus
por: Lorenz, Georg, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rffddhqh87mi054797lvg75q0d